Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
TCTricida, Inc. logo

Tricida, Inc. (TCDA)

NASDAQ Global Select · Currency in USD
$0.11 ▲ +0.00 (+0.00%)
At close: Jan 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.11
Open
$0.12
Day's Range
$0.09 – $0.12
52 Week Range
$0.04 – $13.85
Volume
31,125,310
Avg. Volume
11,432,949
Market Cap
$5.95M
Beta (5Y Monthly)
0.00
PE Ratio (TTM)
--
EPS (TTM)
-$3.88
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$16.00

Profile: Tricida, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
57
CEO
Gerrit Klaerner

Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract.

Earnings

DateEst.Actual
Nov 14, 2022-$0.54-$0.44Beat
Aug 8, 2022-$0.58-$0.49Beat
May 10, 2022-$0.70-$0.51Beat
Dec 31, 2021–-$1.00
Nov 8, 2021-$0.64-$0.79Miss
Aug 9, 2021-$0.84-$0.67Beat

Analyst view

Consensus price target
$16.00 ▲ +14,714.8%
Range $16.00 – $16.00
Rating: Hold
Buy 25% · Hold 50% · Sell 25%

Get free alerts on TCDA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.